📰 Kumar Budur News
Page 4 - Kumar Budur News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kumar Budur. Real-time updates on events, politics, business and more.
July 20, 2023
PLYMOUTH MEETING, Pa., July 20, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. , a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with...
July 20, 2023
The study will further investigate pitolisant in patients with Prader-Willi syndrome experiencing excessive daytime sleepiness.
June 9, 2023
Harmony presented data from a phase 2 study evaluating pitolisant for the treatment of EDS in people with Prader-Willi syndrome.
June 6, 2023
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...
May 26, 2023
Harmony Biosciences has completed enrollment for its phase 3 INTUNE study of pitolisant in adult patients with idiopathic hypersomnia.
May 25, 2023
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...
May 10, 2023
Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa., May 10, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. , a... | May 10, 2023
May 10, 2023
Harmony Biosciences will present new efficacy data from a phase 2 study evaluating pitolisant in patients with Prader-Willi syndrome.
May 2, 2023
HRMY earnings call for the period ending March 31, 2023.